CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 40  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1327
LYS 10.0181
GLU 20.0094
LEU 30.0167
ARG 40.0210
CYS 50.0140
GLN 60.0178
CYS 70.0096
ILE 80.0046
LYS 90.0070
THR 100.0065
TYR 110.0105
SER 120.0108
LYS 130.0160
PRO 140.0230
PHE 150.0238
HIS 160.0287
PRO 170.0130
LYS 180.0207
PHE 190.0228
ILE 200.0160
LYS 210.0207
GLU 220.0190
LEU 230.0097
ARG 240.0156
VAL 250.0102
ILE 260.0105
GLU 270.0144
SER 280.0145
GLY 290.0464
PRO 300.0259
HIS 310.0118
CYS 320.0110
ALA 330.0243
ASN 340.0116
THR 350.0139
GLU 360.0116
ILE 370.0074
ILE 380.0115
VAL 390.0167
LYS 400.0182
LEU 410.0179
SER 420.0142
ASP 430.0232
GLY 440.0207
ARG 450.0366
GLU 460.0221
LEU 470.0220
CYS 480.0100
LEU 490.0044
ASP 500.0162
PRO 510.0217
LYS 520.0294
GLU 530.0147
ASN 540.0139
TRP 550.0123
VAL 560.0070
GLN 570.0214
ARG 580.0211
VAL 590.0103
VAL 600.0151
GLU 610.0265
LYS 620.0141
PHE 630.0137
LEU 640.0196
LYS 650.0173
ARG 660.0232
ALA 670.0313
GLU 680.0552
ASN 690.1327

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.